Raphael Pharmaceutical Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Ofir Guy, was filed 22 Sept 2009.
Raphael Pharmaceutical Inc.: what insiders have been doing
Raphael Pharmaceutical Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 24 October 2026, brought 1 filing signed by 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
For context, the typical company on the same exchange (median of 282 companies) published 8 filings over the same period, against 1 filing here. Over the whole record (from 2008), the tally stands at 18 purchases and no sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported net income of -1.3 m USD.
No insider has bought Raphael Pharmaceutical Inc. shares on the open market in the past twelve months.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 350,000 shares@ US$0.0124.8% of flowCommon StockSEC:0001213900-26-040590:0
- 200,000 shares@ US$0.50100.0% of flowCommon StockSEC:0001213900-25-022736:0
- 350,000 shares0Common StockSEC:0001213900-25-021172:0
- 150,000 shares@ US$0.40100.0% of flowCommon StockSEC:0001213900-24-025520:0
- 999,000 shares@ US$0.0175.2% of flowCommon StockSEC:0001213900-24-025519:0
- 1,000,000 shares0Common StockSEC:0001213900-23-019553:0
- 280,000 shares0Common StockSEC:0001213900-23-019556:0
- 404,153 shares@ US$0.095Common StockSEC:0001165527-09-000698:0Canonical exit: 2 Dec 2009 (T+90)
- 1,000,000 shares@ US$0.15Common StockSEC:0001165527-09-000698:1Canonical exit: 21 Dec 2009 (T+90)
- 100,000 shares@ US$0.06Common StockSEC:0001165527-08-000751:0Canonical exit: 2 Mar 2009 (T+90)
- 100,000 shares@ US$0.065Common StockSEC:0001165527-08-000751:1Canonical exit: 2 Mar 2009 (T+90)
- 5,000 shares@ US$0.15Common StockSEC:0001165527-08-000735:0Canonical exit: 31 Dec 2008 (T+90)
- 5,000 shares@ US$0.14Common StockSEC:0001165527-08-000735:1Canonical exit: 1 Jan 2009 (T+90)
- 29,800 shares@ US$0.15Common StockSEC:0001165527-08-000735:2Canonical exit: 1 Jan 2009 (T+90)
- 45,000 shares@ US$0.15Common StockSEC:0001165527-08-000736:0Canonical exit: 2 Feb 2009 (T+90)
- 10,000 shares@ US$0.16Common StockSEC:0001165527-08-000736:1Canonical exit: 2 Feb 2009 (T+90)
- 50,000 shares@ US$0.10Common StockSEC:0001165527-08-000736:2Canonical exit: 10 Feb 2009 (T+90)
- 15,000 shares@ US$0.08Common StockSEC:0001165527-08-000736:3Canonical exit: 22 Feb 2009 (T+90)
- 15,000 shares@ US$0.07Common StockSEC:0001165527-08-000736:4Canonical exit: 22 Feb 2009 (T+90)
- 20,000 shares@ US$0.09Common StockSEC:0001165527-08-000736:6Canonical exit: 22 Feb 2009 (T+90)
- 5,000 shares@ US$0.14Common StockSEC:0001165527-08-000572:0Canonical exit: 29 Dec 2008 (T+90)
- 38,500 shares@ US$0.15Common StockSEC:0001165527-08-000572:1Canonical exit: 29 Dec 2008 (T+90)
- 20,000 shares@ US$0.15Common StockSEC:0001165527-08-000557:0Canonical exit: 25 Dec 2008 (T+90)
- 5,000 shares@ US$0.15Common StockSEC:0001165527-08-000557:1Canonical exit: 28 Dec 2008 (T+90)
- 00Common StockSEC:0001165527-08-000557:2Canonical exit: 28 Dec 2008 (T+90)
25 of 25 declarations
About Raphael Pharmaceutical Inc.
Raphael Pharmaceutical Inc. is a company focused on developing innovative pharmaceuticals. It is listed on the XNAS market.
